| Literature DB >> 34308014 |
Muhamad Hanif Rawi1, Aminah Abdullah2, Amin Ismail3, Shahrul Razid Sarbini1,4.
Abstract
Acacia gum (AG) is a branched-polysaccharide gummy exudate that consists of arabinose and galactose. The traditional practice in African-Middle Eastern countries uses this gum as medicine. Traditional use of AG is to treat stomach disease, which can be a potential functional food. In this research, commercially available AG from Acacia senegal and Acacia seyal was investigated as the prebiotic. The experiment employed a pH-controlled in vitro colon model inoculated with human fecal microbiota to mimic the human colon. Fermentation samples at 0, 6, 12, and 24 h were brought for short-chain fatty acid (SCFA) analysis using high-performance liquid chromatography and bacterial enumeration via fluorescent in situ hybridization. Results showed that AG significantly promotes Bifidobacteria proliferation similar to fructo-oligosaccharides (FOS) while inhibiting the Clostridium histolyticum group, commonly associated with gut dysbiosis. Acetate, propionate, and butyrate showed a similar trend to FOS (p > 0.05). The AG shows potential against gut dysbiosis, as it promotes gut-probiotics, through modulation of microbial population and SCFA production, especially butyrate.Entities:
Year: 2021 PMID: 34308014 PMCID: PMC8296006 DOI: 10.1021/acsomega.1c00302
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Proximate Analysis of AG1 and AG2 for the Content (%) of Total Crude Protein, Fat, Moisture, Ash, and Carbohydratea
| component | AG1 | AG2 |
|---|---|---|
| protein | 1.86 ± 0.04 a | 0.85 ± 0.02 b |
| moisture | 11.95 ± 0.05 a | 10.40 ± 0.03 b |
| fat | 0.08 ± 0.02 a | 0.06 ± 0.03 a |
| ash | 3.21 ± 0.01 a | 3.50 ± 0.02 a |
| carbohydrate (by difference) | 82.92 a | 85.22 b |
All data are shown as mean ± SD, n = 3. Means with a lowercase letter represent significant nutrient composition in terms of percentage (%) between AG samples at a confidence level of 95.0%. (n = 3).
Figure 1Total carbohydrate content (mg/mL) of fructo-oligosaccharides and acacia gum. Means with a lowercase letter shows the significant comparison of samples before and after digestion at a confidence level of 95.0%. (n = 3) (Note: FOS, fructo-oligosaccharides; AG1, A. senegal; AG2, mix of A. senegal and A. seyal).
Figure 2Total reducing sugar content (mg/mL) of fructo-oligosaccharides and acacia gum. Means with a lowercase letter shows the significant comparison of samples before and after digestion at a confidence level of 95.0%. (n = 3) (Note: FOS, fructo-oligosaccharides; AG1, A. senegal; AG2, mix of A. senegal and A. seyal).
Mean Values of the Bacterial Population (log10 Cells/mL) in the Batch Culture Colon Model Fermentation at 0, 6, 12, and 24 h by Human Faecal Microbiotaa
| probe | time (h) | mean ± SD | |||
|---|---|---|---|---|---|
| AG1 | AG2 | FOS | control | ||
| Bif164 | 0 | 7.94 ± 0.12 | 7.94 ± 0.12 | 7.94 ± 0.12 | 7.94 ± 0.12 |
| 6 | 8.28 ± 0.16 ab | 8.25 ± 0.21 ab | 8.47 ± 0.14 a | 8.19 ± 0.09 b | |
| 12 | 8.51 ± 0.04 a | 8.54 ± 0.11 a | 8.47 ± 0.12 a | 8.41 ± 0.08 a | |
| 24 | 8.59 ± 0.04 a | 8.78 ± 0.10 a | 8.67 ± 0.08 a | 8.41 ± 0.06 b | |
| Lab158 | 0 | 7.88 ± 0.23 | 7.88 ± 0.23 | 7.88 ± 0.23 | 7.88 ± 0.23 |
| 6 | 8.01 ± 0.36 a | 8.19 ± 0.23 a | 8.14 ± 0.07 a | 7.96 ± 0.15 a | |
| 12 | 8.11 ± 0.24 ab | 8.14 ± 0.21 ab | 8.09 ± 0.21 a | 8.18 ± 0.20 b | |
| 24 | 8.08 ± 0.12 a | 8.13 ± 0.25 a | 7.99 ± 0.27 a | 8.12 ± 0.28 a | |
| Chis150 | 0 | 7.22 ± 0.14 | 7.22 ± 0.14 | 7.22 ± 0.14 | 7.22 ± 0.14 |
| 6 | 7.46 ± 0.14 a | 7.67 ± 0.21 b | 7.34 ± 0.17 c | 7.28 ± 0.17 d | |
| 12 | 7.36 ± 0.03 a | 7.39 ± 0.07 a | 7.15 ± 0.08 b | 7.24 ± 0.11 ab | |
| 24 | 7.18 ± 0.08 a | 7.20 ± 0.14 ab | 7.29 ± 0.15 ab | 7.32 ± 0.09 b | |
| Ato291 | 0 | 7.93 ± 0.14 | 7.93 ± 0.14 | 7.93 ± 0.14 | 7.93 ± 0.14 |
| 6 | 8.14 ± 0.25 a | 8.15 ± 0.25 a | 8.17 ± 0.15 a | 8.07 ± 0.07 a | |
| 12 | 8.32 ± 0.14 a | 8.35 ± 0.11 a | 8.36 ± 0.02 ab | 8.00 ± 0.18 b | |
| 24 | 8.34 ± 0.06 ab | 8.38 ± 0.10 ab | 8.35 ± 0.14 a | 8.16 ± 0.20 b | |
| Erec482 | 0 | 7.81 ± 0.09 | 7.81 ± 0.09 | 7.81 ± 0.09 | 7.81 ± 0.09 |
| 6 | 7.51 ± 0.04 a | 7.59 ± 0.03 b | 7.55 ± 0.17 ab | 7.57 ± 0.05 ab | |
| 12 | 7.58 ± 0.10 a | 7.58 ± 0.13 a | 7.56 ± 0.03 a | 7.53 ± 0.03 a | |
| 24 | 7.55 ± 0.04 a | 7.52 ± 0.10 a | 7.54 ± 0.09 a | 7.56 ± 0.05 a | |
| Prop853 | 0 | 7.40 ± 0.15 | 7.40 ± 0.15 | 7.40 ± 0.15 | 7.40 ± 0.15 |
| 6 | 7.37 ± 0.06 a | 7.37 ± 0.16 a | 7.33 ± 0.19 a | 7.36 ± 0.17 a | |
| 12 | 7.31 ± 0.09 a | 7.36 ± 0.09 a | 7.32 ± 0.10 a | 7.48 ± 0.10 b | |
| 24 | 7.30 ± 0.13 ab | 7.27 ± 0.21 ab | 7.23 ± 0.11 a | 7.40 ± 0.18 b | |
| Fpra655 | 0 | 7.61 ± 0.08 | 7.61 ± 0.08 | 7.61 ± 0.08 | 7.61 ± 0.08 |
| 6 | 7.63 ± 0.23 a | 7.59 ± 0.44 a | 7.65 ± 0.24 a | 7.69 ± 0.13 a | |
| 12 | 7.64 ± 0.30 a | 7.67 ± 0.13 a | 7.69 ± 0.23 a | 7.64 ± 0.05 a | |
| 24 | 7.67 ± 0.14 a | 7.69 ± 0.17 a | 7.64 ± 0.20 a | 7.50 ± 0.05 a | |
| Bac303 | 0 | 8.22 ± 0.19 | 8.22 ± 0.19 | 8.22 ± 0.19 | 8.22 ± 0.19 |
| 6 | 8.29 ± 0.07 a | 8.30 ± 0.03 a | 8.26 ± 0.14 a | 8.25 ± 0.11 a | |
| 12 | 8.36 ± 0.37 ab | 8.45 ± 0.21 ab | 8.51 ± 0.02 a | 8.35 ± 0.08 b | |
| 24 | 8.56 ± 0.02 ab | 8.56 ± 0.14 b | 8.63 ± 0.06 b | 8.30 ± 0.13 a | |
| Bac338 | 0 | 8.53 ± 0.21 | 8.53 ± 0.21 | 8.53 ± 0.21 | 8.53 ± 0.21 |
| 6 | 8.57 ± 0.09 a | 8.56 ± 0.16 a | 8.73 ± 0.15 a | 8.56 ± 0.08 a | |
| 12 | 8.60 ± 0.12 a | 8.64 ± 0.09 ab | 8.76 ± 0.10 b | 8.52 ± 0.17 a | |
| 24 | 8.71 ± 0.09 ab | 8.70 ± 0.20 a | 8.73 ± 0.10 ab | 8.50 ± 0.18 b | |
All data are shown as mean ± SD, n = 4. Means with a lowercase letter represent significant differences between substrates within the same sampling hour (p < 0.05).
Mean value represents significant differences from the 0 h value within the same treatment (p < 0.05).
Bif164, Bifidobacterium spp.; Lab158, Lactobacillus/Enterococcus; Chis150, Clostridium histolyticum; Ato291, Atopobium spp.; Erec482, Eubacterium rectale-Clostridium coccoides; Prop853, Clostridium cluster XI; Fpra655, Faecalibacterium prausnitzii; Bac303, most Bacteroidaceae and Prevotellaceae, some Porphyromonadaceae: Bac338, total bacteria.
Figure 3Concentration of short-chain fatty acids against time for AG1. Means with a lowercase letter shows the significant comparison between hours of each acids at a confidence level of 95.0%. (n = 4).
Figure 6Concentration of short-chain fatty acids against time for control. Means with a lowercase letter shows the significant comparison between hours of each acids at a confidence level of 95.0%. (n = 4).
Figure 5Concentration of short-chain fatty acids against time for AG2. Means with a lowercase letter shows the significant comparison between hours of each acids at a confidence level of 95.0%. (n = 4).
Figure 4Concentration of short-chain fatty acids against time for FOS. Means with a lowercase letter shows the significant comparison between hours of each acids at a confidence level of 95.0%. (n = 4).
16S rRNA Oligonucleotide Probes Used in the Present Study
| probe code | specificity | sequence (5′ to 3′) | temperature condition (°C) | ||
|---|---|---|---|---|---|
| hybridization | washing | ||||
| Chis150 | most of the
bacteria in the | TTATGCGGTATTAATCTYCCTTT | 50 | 50 | Franks et al.[ |
| Lab158 | GGTATTAGCAYCTGTTTCCA | 50 | 50 | Harmsen et al.[ | |
| Erec482 | most of the bacteria in the | GCTTCTTAGTCARGTACCG | 50 | 50 | Franks et al.[ |
| Bif164 | CATCCGGCATTACCACCC | 50 | 50 | Langendijk et al.[ | |
| Bac303 | most | CCAATGTGGGGGACCTT | 46 | 48 | Manz et al.[ |
| Ato291 | GGTCGGTCTCTCAACCC | 50 | 50 | Harmsen et al.[ | |
| Prop853 | ATTGCGTTAACTCCGGCAC | 50 | 50 | Walker et al.[ | |
| Fpra655 | CGCCTACCTCTGCACTAC | 58 | 58 | Hold et al.[ | |
| EUB338 | GCTGCCTCCCGTAGGAGT | ||||
| EUB338II | total bacteria | GCAGCCACCCGTAGGTGT | 46 | 48 | Daims et al.[ |
| EUB338III | GCTGCCACCCGTAGGTGT | ||||
These probes are used together in equimolar concentrations (all at 50 ng μL–1).